Indiana coronavirus updates for June 9, 2022
The latest updates on the coronavirus pandemic for Thursday, June 9, 2022.
INDIANAPOLIS – Here are Thursday’s latest updates on the coronavirus pandemic, including the latest on COVID-19 vaccinations and testing in Indiana.
RELATED: Here’s Everything We Know About the COVID-19 Vaccine
RELATED: Biden administration launches covid.gov site
Latest US and Global Numbers
There had been more than 85.21 million confirmed cases of COVID-19 in the United States as of 4:30 a.m. ET Thursday, according to Johns Hopkins University. There have been more than 1,010,520 recorded deaths in the United States
Worldwide, there have been over 533.67 million confirmed cases of coronavirus with over 6.30 million deaths and over 11.52 billion doses of vaccine administered.
For most people, the coronavirus causes mild or moderate symptoms. For some, especially older people and people with existing health conditions, it can lead to more serious illnesses like pneumonia or death.
Moderna says updated COVID shot bolsters omicron protection
Moderna’s experimental COVID-19 vaccine that combines its original vaccine with protection against the omicron variant appears to work, the company announced Wednesday.
COVID-19 vaccine makers are studying updated boosters that could be offered in the fall to better protect people from future coronavirus outbreaks.
Preliminary results from Moderna’s study show that people receiving the combination vaccine experienced an eight-fold increase in anti-virus antibodies able to target the omicron mutant, the company said.
Today’s COVID-19 vaccines are all based on the original version of the coronavirus. They still provide strong protection against serious illness, hospitalization and death, even after the super-contagious omicron variant emerges, especially if people have been given a booster dose.
But the virus continues to rapidly mutate in ways that evade some of the vaccine protections and cause milder infections.
US regulators and the World Health Organization are therefore considering ordering a change in the vaccine recipe for a new round of boosters in the fall – when cold weather and the return of children to school are expected to lead to a new push.
FDA advisers back Novavax COVID-19 injections as new US option
American adults who have not yet been vaccinated against COVID-19 may soon have another choice, as Food and Drug Administration advisers backed a more traditional type of vaccine on Tuesday.
Next, the FDA must decide whether or not to license the vaccine made by latecomer Novavax, a protein vaccine made with more conventional technology than current US options.
Novavax injections are already used in Australia, Canada, parts of Europe and dozens of other countries. But US customs clearance is a major hurdle for the Maryland-based company.
FDA vaccine chief Dr. Peter Marks said another choice in the United States could make at least some vaccine holders — whatever their reason — consider rolling up their sleeves.
If the FDA clears Novavax as the nation’s fourth vaccine, it’s unclear to what extent it would be used — at least right away. About 27 million American adults are still unvaccinated. Eventually, Novavax also hopes to become a choice for the millions of others who have yet to receive a booster dose of current vaccines. Injections are used elsewhere as a booster, regardless of which vaccine people originally received.
MORE: FDA advisers back Novavax COVID-19 injections as new US option
CDC map shows 13 Indiana counties at ‘medium’ risk
As of Thursday, June 9, 2022, 13 Indiana counties (LaPorte, St. Joseph, Starke, Marshall, Pulaski, Fulton, Benton, White, Tippecanoe, Carroll, Clinton, Lawrence, Orange) were listed on the CDC data card as having a “medium” community risk of spreading COVID-19. Around Indiana, the metropolitan areas of Louisville (medium) and Chicago (high) are also deemed at risk by the CDC.
CDC data shows 82 million vaccine doses are wasted
Pharmacies, states, U.S. territories, and federal agencies rejected 82.1 million doses of COVID-19 vaccine from December 2020 to mid-May 2022, just over 11% of federally distributed doses , according to data from the Centers for Disease Control and Prevention. shared with NBC News.
This is an increase from the 65 million doses the CDC told The Associated Press it was wasted in late February.
Two retail pharmacy chains, CVS and Walmart, were responsible for more than a quarter of the doses thrown away in the United States during that period, in part because of the sheer volume of vaccines they handled.
Five other pharmacies or dialysis centers — Health Mart, DaVita, Rite Aid, Publix and Costco — wasted fewer overall doses, but a higher share: more than a quarter of the vaccine doses they received, well over above the national average. Two states also threw away more than a quarter of their doses: Oklahoma, which threw away 28% of the nearly 4 million doses it received, and Alaska, which threw away nearly 27% of its 1 million doses, according to CDC data.
The overall amount of waste is in line with World Health Organization estimates for major vaccination campaigns. But public health experts said the wastage is still alarming at a time when less than half of fully vaccinated Americans receive a booster shot, which is critical to tackle newer, more contagious virus strains – and as many poor countries continue to struggle with vaccine supplies.
US makes COVID-19 antiviral drug more available at testing sites
The White House announced new measures to make the antiviral treatment Paxlovid more accessible across the United States as it anticipates COVID-19 infections will continue to spread during the summer travel season.
The first federally-supported testing site for treatment opens Thursday in Rhode Island. The site will offer patients immediate access to the drug once they test positive.
Other federally-supported sites are expected to open in the coming weeks in Massachusetts and New York, both hit by marked increases in infections.
Next week, the United States will send authorized federal prescribers to several Minnesota-run testing sites, turning them into testing sites to treat.
RELATED: Administration expands availability of COVID antiviral pill
The White House offers 8 additional free COVID-19 tests to the public
The government website for people to request free home COVID-19 tests from the US government is now accepting a third round of orders.
The White House recently announced that American households can request that eight additional free home tests be shipped by the US Postal Service.
President Joe Biden pledged in January to make 1 billion tests available to the public for free, including 500 million through covidtests.gov. But only 350 million of the amount available for online ordering has been shipped so far to addresses across the continental United States, its territories and overseas military bases, the White House said.
People who are having trouble logging in or need help placing an order can call 1-800-232-0233 for assistance.
Round three brings the total number of free tests available to every US household to 16 since the program began earlier this year. Households were eligible to receive four tests during each of the previous two rounds of ordering through the website.
2nd COVID-19 reminder available for Hoosiers 50+
The Indiana Department of Health has announced that Hoosiers age 50 and older, as well as those age 12 and older with compromised immune systems, are now eligible to receive a second COVID-19 mRNA booster. at least four months after their first booster dose.
The announcement comes a day after the Food and Drug Administration authorized an additional dose of the Pfizer or Moderna vaccine for this age group and some younger people with severely weakened immune systems.
The Centers for Disease Control and Prevention later recommended the additional injection as an option, but did not urge eligible people to rush in and get it immediately.
IDOH is advising vaccine providers that they can begin giving second boosters of Moderna and Pfizer vaccines to eligible people.
The CDC also says adults who received a primary vaccine and a booster dose of the Johnson & Johnson vaccine at least four months ago can now receive a second booster dose of either mRNA vaccine. .
You can find a vaccination point at ourshot.in.gov or by calling Indiana 211 (866-211-9966). Appointments are recommended, but many sites accept walk-ins.